Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Meldola
Clinical trial register · Italy

Clinical Trials in Meldola, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 98 Roma 43 Naples 40 Rome 40 Rozzano 27
Narrow the registerReset
Recruitment status
Phase
Site location
Milan98 Roma43 Naples40 Rome40 Rozzano27
All 66 locations
Target enrolment
to

Trials with a site in Meldola

22 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
140
Meldola
2026-04-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Meldola, Rozzano, Catselfranco Veneto, Florence, Bari, Bologna, Milan, Perugia
2026-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
170
Meldola, Milan, Roma
2026-01-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Meldola, Aviano, Milan, Brescia, Catania, Padova, Roma, Torino
2026-01-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Bolzano, Modena, Meldola, Udine, Rome, Bergamo, Rozzano, Statte
2025-10-08
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
160
Meldola, Milan, Pisa
2024-09-20
Recruiting
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT06445972Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
Merck Sharp & Dohme LLC
Phase 1/2
210
Meldola, Milan, Pisa
2024-08-07
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Meldola, Milan
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Cona, Meldola, Milan, Florence, Pisa, Castelfranco Veneto, Alessandria, Ancona
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Meldola, Milan, Catania, Foggia, Terni
2023-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Bari, Meldola, Rome, Milan, Orbassano, Florence, Arezzo, Bologna
2022-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Naples, Bologna, Meldola, Milan, Turin, Rome, Florence, Vicenza
2022-02-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Meldola, Rozzano, Orbassano, Arezzo, Bari, Milan, Pavia, Roma
2021-02-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Meldola, Bari, Bergamo, Genova, Milan, Naples, Padova, Roma
2018-09-12
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/meldola

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Meldola that also match the filters currently applied.

How many clinical trials are recruiting in Meldola?

15 of the 22 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Meldola), 22 studies
PhaseStudiesRecruitingShare
Phase 316972.7%
Phase 1/25522.7%
Phase 2114.5%

Most active sponsors

Lead sponsors with the most studies (Meldola)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC2215
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.